Page last updated: 2024-09-03

gyki 53655 and morphine

gyki 53655 has been researched along with morphine in 1 studies

Compound Research Comparison

Studies
(gyki 53655)
Trials
(gyki 53655)
Recent Studies (post-2010)
(gyki 53655)
Studies
(morphine)
Trials
(morphine)
Recent Studies (post-2010) (morphine)
11102244,2705,2008,695

Protein Interaction Comparison

ProteinTaxonomygyki 53655 (IC50)morphine (IC50)
Delta-type opioid receptorMus musculus (house mouse)0.2939
Delta-type opioid receptorRattus norvegicus (Norway rat)0.2278
Kappa-type opioid receptorMus musculus (house mouse)0.0828
Mu-type opioid receptorRattus norvegicus (Norway rat)0.0385
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.0545
Mu-type opioid receptorHomo sapiens (human)0.122
Delta-type opioid receptorHomo sapiens (human)0.1199
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.9308
Kappa-type opioid receptorHomo sapiens (human)0.655
Mu-type opioid receptorMus musculus (house mouse)0.3305
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.202
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)0.25

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rasmussen, K; Vandergriff, J1

Other Studies

1 other study(ies) available for gyki 53655 and morphine

ArticleYear
The selective iGluR1-4 (AMPA) antagonist LY300168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal.
    Neuropharmacology, 2003, Volume: 44, Issue:1

    Topics: Allosteric Regulation; Animals; Behavior, Animal; Benzodiazepines; Dose-Response Relationship, Drug; Electrophysiology; Excitatory Amino Acid Antagonists; Isoquinolines; Locus Coeruleus; Male; Morphine; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Substance Withdrawal Syndrome

2003